Home Equities Score Aridis Pharmaceuticals Inc. (ARDS) stock plunges during current market. Here’s the update

Aridis Pharmaceuticals Inc. (ARDS) stock plunges during current market. Here’s the update

Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) stock declines during the current market by 11.11%. Aridis Pharmaceuticals, Inc. researches and develops anti-infectives that can be used in conjunction with conventional antibiotics to treat infections.

Current Development

Aridis Pharmaceuticals has signed an exclusive, global licensing deal with AstraZeneca to in-license suvratoxumab, a late-stage monoclonal antibody product.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The following are the key points of the contract:

  • Candidate for Phase 3 AstraZeneca has licensed Suvratoxumab, a monoclonal antibody (mAb) for the prevention of pneumonia. Suvratoxumab complements Aridis’ current AR-301 Phase 3 pneumonia therapy development, extending the company’s pneumonia business.
  • This is a Lancet ID publication. Protection and a statistical significance (47 percent) relative decrease of pneumonia in S. aureus colonized, mechanically ventilated patients less than 65 years old were authored in The Lancet Infectious Diseases journal, with correlating decrease in the amount of days needed in the ICU and hospital.
  • Up to €25 million in financing (about $30 million) is available. Suvratoxumab Phase 3 clinical trial is being funded by the EU Commission’s Innovative Medicines Initiatives.
  • The ownership interest in Aridis held by AstraZeneca. Through the issuing of common stock, AstraZeneca becomes a stakeholder of Aridis and has the right of first negotiation for future licensing

Official Statements

Vu Truong, Aridis’ Chief Executive Officer stated,

They are honored to be chosen as AstraZeneca’s licensee. The excellent findings from the Phase 2 trial offer them an edge in defining the patient group, main endpoint, and clinical study design for the Phase 3 confirmatory trial, paving the way for a clear route to the Phase 3 confirmatory trial.

Mark Esser, Vice President, Microbial Sciences, AstraZeneca commented,

Suvratoxumab has the potential to revolutionize the treatment of lung infections in ventilated patients. They are happy to finalize this licensing agreement with Aridis, who they feel will be a strong partner in the development of suvratoxumab.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

DMC Global Inc. (BOOM) stock declines during pre-market trading. Here’s what you should know

DMC Global Inc. (NASDAQ: BOOM) stock plunged by 6.50% at last close while the BOOM stock price fell further by 13.06% in the pre-market...

Boston Beer Company Inc. (SAM) stock fell during after-hour trading. Here’s the recent update

Boston Beer Company Inc. (NASDAQ: SAM) stock gains by 1.89% at last close whereas the SAM stock price plunged by 18.64% in the after-hours...

Jupiter Wellness, Inc. (JUPW) Stock Plummets Following Pricing of Underwritten Public Offering

Jupiter Wellness, Inc. (JUPW) stock prices were down 15.45% as of the market closing on July 21st, 2021, bringing the price per share down...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam